Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1971 2
1972 1
1973 1
1974 1
1975 2
1976 3
1977 1
1979 5
1981 2
1982 6
1983 7
1984 4
1985 7
1986 3
1987 10
1988 2
1989 11
1990 3
1991 2
1992 7
1993 3
1994 6
1995 10
1996 9
1997 11
1998 12
1999 14
2000 19
2001 13
2002 17
2003 9
2004 12
2005 12
2006 18
2007 13
2008 25
2009 25
2010 18
2011 17
2012 24
2013 32
2014 30
2015 16
2016 19
2017 17
2018 28
2019 24
2020 27
2021 15
2022 13
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

540 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pancreatic agenesis 1"
Page 1
Type 2 diabetes mellitus.
DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R. DeFronzo RA, et al. Nat Rev Dis Primers. 2015 Jul 23;1:15019. doi: 10.1038/nrdp.2015.19. Nat Rev Dis Primers. 2015. PMID: 27189025 Review.
Insulin resistance and impaired insulin secretion remain the core defects in T2DM, but at least six other pathophysiological abnormalities contribute to the dysregulation of glucose metabolism. ...Several novel medications are in development, but the greatest need is for a …
Insulin resistance and impaired insulin secretion remain the core defects in T2DM, but at least six other pathophysiological abnormalitie …
Euglycemic diabetic ketoacidosis.
Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Barski L, et al. Eur J Intern Med. 2019 May;63:9-14. doi: 10.1016/j.ejim.2019.03.014. Epub 2019 Mar 23. Eur J Intern Med. 2019. PMID: 30910328 Review.

Euglycemic DKA (eu-DKA) is a life-threatening emergency. It may occur in patients with both type 1 and type 2 DM, and characterized by milder degrees of hyperglycemia with blood glucose level < 200 mg/dl, which can result in delayed diagnosis and treatment with potentia

…
Euglycemic DKA (eu-DKA) is a life-threatening emergency. It may occur in patients with both type 1 and type 2 DM, and characterized b …
Maturity-onset diabetes of the young (MODY): an update.
Anık A, Çatlı G, Abacı A, Böber E. Anık A, et al. J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):251-63. doi: 10.1515/jpem-2014-0384. J Pediatr Endocrinol Metab. 2015. PMID: 25581748 Review.
Sulfonylureas are effective in these patients by acting on adenosine triphosphate (ATP)-sensitive potassium channels, although insulin therapy may be required later in life. Mutations in the HNF1B (MODY 5) is associated with pancreatic agenesis, renal abnormaliti …
Sulfonylureas are effective in these patients by acting on adenosine triphosphate (ATP)-sensitive potassium channels, although insulin thera …
IgG4-related kidney disease.
Saeki T, Kawano M. Saeki T, et al. Kidney Int. 2014 Feb;85(2):251-7. doi: 10.1038/ki.2013.393. Epub 2013 Oct 9. Kidney Int. 2014. PMID: 24107849 Free article. Review.
IgG4-related kidney disease (IgG4-RKD) is a comprehensive term for renal lesions associated with IgG4-related disease, which is a recently recognized clinical entity characterized by a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells with fibrosis affe …
IgG4-related kidney disease (IgG4-RKD) is a comprehensive term for renal lesions associated with IgG4-related disease, which is a recently r …
Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?
Balk RA. Balk RA. Virulence. 2014 Jan 1;5(1):20-6. doi: 10.4161/viru.27135. Epub 2013 Nov 13. Virulence. 2014. PMID: 24280933 Free PMC article. Review.
The concept of a systemic inflammatory response syndrome (SIRS) to describe the complex pathophysiologic response to an insult such as infection, trauma, burns, pancreatitis, or a variety of other injuries came from a 1991 consensus conference charged with the task of deve …
The concept of a systemic inflammatory response syndrome (SIRS) to describe the complex pathophysiologic response to an insult such as infec …
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.
Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Lim EL, et al. Diabetologia. 2011 Oct;54(10):2506-14. doi: 10.1007/s00125-011-2204-7. Epub 2011 Jun 9. Diabetologia. 2011. PMID: 21656330 Free PMC article. Clinical Trial.
METHODS: Eleven people with type 2 diabetes (49.5 2.5 years, BMI 33.6 1.2 kg/m(2), nine male and two female) were studied before and after 1, 4 and 8 weeks of a 2.5 MJ (600 kcal)/day diet. ...Maximal insulin response became supranormal at 8 weeks (1.37 0.27 v …
METHODS: Eleven people with type 2 diabetes (49.5 2.5 years, BMI 33.6 1.2 kg/m(2), nine male and two female) were studied before and …
Acute pancreatitis.
Geokas MC, Baltaxe HA, Banks PA, Silva J Jr, Frey CF. Geokas MC, et al. Ann Intern Med. 1985 Jul;103(1):86-100. doi: 10.7326/0003-4819-103-1-86. Ann Intern Med. 1985. PMID: 3890660 Review.
In-vivo autodigestion is prevented by an array of natural safeguards. In acute pancreatitis, inappropriate intrapancreatic activation and release of pancreatic hydrolases occur, but the pathogenetic mechanism of autodigestion is unclear. The release of proteases, li …
In-vivo autodigestion is prevented by an array of natural safeguards. In acute pancreatitis, inappropriate intrapancreatic activation …
Shwachman Diamond syndrome: narrow genotypic spectrum and variable clinical features.
Thompson AS, Giri N, Gianferante DM, Jones K, Savage SA, Alter BP, McReynolds LJ. Thompson AS, et al. Pediatr Res. 2022 Dec;92(6):1671-1680. doi: 10.1038/s41390-022-02009-8. Epub 2022 Mar 23. Pediatr Res. 2022. PMID: 35322185 Free PMC article. Review.
Most patients had the SDS hallmark features of neutropenia (45/45, 100%), pancreatic insufficiency (41/43, 95.3%), and/or bony abnormalities (29/36, 80.6%). ...Coordinated multidisciplinary care is important for diagnosis and patient management. CLINICAL T …
Most patients had the SDS hallmark features of neutropenia (45/45, 100%), pancreatic insufficiency (41/43, 95.3%), and/or bony abn …
GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Popovic DS, Stokic E, Popovic SL. Popovic DS, et al. Curr Pharm Des. 2015;21(36):5292-8. doi: 10.2174/0929867322666151006142224. Curr Pharm Des. 2015. PMID: 26438316 Review.
Type 1 diabetes (T1DM) is a disease characterized by autoimmune mediated destruction of the insulin producing beta cells of endocrine pancreas. ...GLP-1 exerts its effects through the interaction with GLP-1 receptor expressed in the pancreatic i …
Type 1 diabetes (T1DM) is a disease characterized by autoimmune mediated destruction of the insulin producing beta cells of endocrine …
Parathyroidectomy for adults with primary hyperparathyroidism.
Pappachan JM, Lahart IM, Viswanath AK, Borumandi F, Sodi R, Metzendorf MI, Bongaerts B. Pappachan JM, et al. Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2. Cochrane Database Syst Rev. 2023. PMID: 36883976 Free PMC article. Review.
Our secondary outcomes were 1. all-cause mortality, 2. health-related quality of life and 3. hospitalisation for hypercalcaemia, acute renal impairment or pancreatitis. ...Of the 223 participants (37 men) randomised to surgery, 164 were included in the analys …
Our secondary outcomes were 1. all-cause mortality, 2. health-related quality of life and 3. hospitalisation for hypercalcaemia, acut …
540 results